Introduction: To reduce the risk of decompression sickness (DCS), current USAF U-2 operations require a 1-h preoxygenation (PreOx). An interruption of oxygen breathing with air breathing currently requires signifi cant extension of the PreOx time. The purpose of this study was to evaluate the relationship between air breaks during PreOx and subsequent DCS and venous gas emboli (VGE) incidence, and to determine safe air break limits for operational activities. Methods: Volunteers performed 30 min of PreOx, followed by either a 10-min, 20-min, or 60-min air break, then completed another 30 min of PreOx, and began a 4-h altitude chamber exposure to 9144 m (30,000 ft). Subjects were monitored for VGE using echocardiography. Altitude exposure was terminated if DCS symptoms developed. Control data (uninterrupted 60-min PreOx) to compare against air break data were taken from the AFRL DCS database. Results: At 1 h of altitude exposure, DCS rates were signifi cantly higher in all three break in prebreathe (BiP) profi les compared to control (40%, 45%, and 47% vs. 24%). At 2 h, the 20-min and 60-min BiP DCS rates remained higher than control (70% and 69% vs. 52%), but no differences were found at 4 h. No differences in VGE rates were found between the BiP profi les and control. Discussion: Increased DCS risk in the BiP profi les is likely due to tissue renitrogenation during air breaks not totally compensated for by the remaining PreOx following the air breaks. Air breaks of 10 min or more occurring in the middle of 1 h of PreOx may signifi cantly increase DCS risk during the fi rst 2 h of exposure to 9144 m when compared to uninterrupted PreOx exposures. Keywords: denitrogenation , renitrogenation , venous gas emboli , break in prebreathe .
A LTITUDE DECOMPRESSION sickness (DCS) is caused by gas bubble formation resulting from tissue nitrogen (N 2 ) supersaturation. The pressure of bubbles on vessels, nerves, and other tissues causes an array of symptoms, mostly joint pain, but can also include skin, respiratory, and central nervous system symptoms. Although mild joint pain DCS may not be reported by a busy crewmember, more severe pain can interfere with performance by distraction or limited capability to move. Other more serious symptoms involve the pulmonary system, or the central nervous system, and can also result in performance degradation, incapacitation, and may even be fatal. The long-standing operational response to DCS symptoms is descent and the use of 100% oxygen (O 2 ) breathing before and during fl ight. With the use of these procedures and with the advent and use of pressurized aircraft cabins since WWII, the incidence of fatal altitude DCS is virtually nonexistent.
The risk of DCS is routinely reduced by breathing 100% O 2 (preoxygenation or prebreathing) as a means to remove tissue N 2 prior to ascent to altitude. These preoxygenation (PreOx) procedures are used to support high altitude reconnaissance aircraft fl ights, high altitude airdrop/parachuting, high altitude fl ights in unpressurized aircraft, hypoxia training in altitude chambers, and extravehicular activity in space. In U-2 operations, 1 h of PreOx is a requirement before commencement of a mission. During such PreOx periods, unavoidable unplanned interruptions in O 2 breathing can occur. " Breaks in prebreathe " (BiP) are handled several ways. In some cases, the PreOx period is started over, in some cases the break is ignored, and in some cases an improvised " payback " schedule is used. There are no published data to support these procedures.
Little conclusive data has been published on the effect of an air break during PreOx on DCS incidence. Bateman ( 4 ) evaluated long PreOx periods and long air breaks in PreOx, and found that there was little impact on DCS from the air breaks. Clarke et al. ( 7 ) showed that a 90 min air break after the PreOx period greatly increased the DCS rate. Cooke ( 9 ) addressed this question by evaluating the effects of 5-min and 10-min air breaks on DCS incidence at different times during PreOx. These breaks were tested in a 60-, 120-, and 180-min PreOx followed by exposures to 10,058 m (33,000 ft) for 2 h. The control, which was uninterrupted PreOx, resulted in no reported cases of DCS in 17 subjects. One of the six profi les with an air break resulted in two cases of DCS and the other fi ve profi les with an air break resulted in one case each of DCS. Thus, they found no signifi cant effect of any interruption in PreOx (taken individually or summed together) on DCS incidence. Because of the small sample size, no scientifi cally sound conclusions could be drawn from these data. Barer et al. ( 5 ) concluded from their study that a 3-min air break after a 2-h PreOx with exposures to 9296 m (30,500 ft) for 4 h including exercise signifi cantly increased the subsequent incidence of DCS, and that a 10-min BiP was not different from a 3-min BiP. However, the breathing gas varied from 89 to 95% O 2 . Due to this variability in the results in the literature on the effect of an air break during PreOx on DCS incidence, no defi nitive conclusions can be drawn.
The purpose of this study was to defi ne the relationship between an air break during a 1-h PreOx and the subsequent DCS and venous gas emboli (VGE) incidence. We hypothesized that a relatively short (10-to 20-min) BiP would not result in a signifi cantly higher incidence of DCS or VGE during a subsequent altitude exposure when compared to a PreOx of equal time without an air break. A relatively short BiP would likely only impact the fast N 2 -exchange tissues, tissues such as blood that quickly equilibrate to a new partial pressure of N 2 . The renitrogenation during air breathing would be erased rapidly when O 2 breathing was resumed. Further, the denitrogenation process initiated at the start of PreOx would continue in the slower tissues during the short " break. " Since most altitude DCS symptoms are caused by bubbles in the slow tissues, there would be no impact on DCS incidence.
Our hypothesis continued that with longer air breaks (60 min), the DCS and VGE incidences would be significantly greater than those in the same exposure without the air break. The hypothesis was that 60 min of breathing air would be suffi cient time to completely renitrogenate fast tissues, those that are well-perfused, and to begin renitrogenation of the less well-perfused tissues. This renitrogenation would nullify the partial denitrogenation that we believed would continue during the 10-to 20-min air break exposures. It was our intent that the data from this study might make it possible to determine the maximum acceptable air break in the middle of a 1-h PreOx, might provide a rationale to modify existing compensation tables and procedures, and would therefore benefi t all operations requiring PreOx.
METHODS

Subjects
The voluntary, fully informed consent of the subjects was obtained in accordance with a protocol approved by the USAF Surgeon General's Research Compliance offi ce in accordance with existing regulations. All subjects passed an appropriate physical examination and were representative of the USAF rated aircrew population. They were not allowed to participate in scuba diving, hyperbaric exposures, or fl ying for at least 48 h before each scheduled altitude exposure. Prior to each altitude exposure, a physician conducted a short physical examination of subjects to identify any signs of illness or other problem that would endanger the subject or bias the experimental results. The subjects received a briefi ng on the morning of each exposure which emphasized their responsibility to report any DCS symptoms or change in well-being to chamber personnel and a list of symptoms was posted in plain view inside the chamber. Air Force Research Laboratory (AFRL) Medical Monitors insured subject health and safety, and made the diagnosis of DCS.
Equipment
All altitude research exposures were accomplished in an altitude chamber used for scientifi c research with human subjects at Brooks AFB/City-Base, TX. A neckseal respirator made by Intertechnique w (Plaisir Cedex, France) was used to deliver the breathing gas. This mask provided a slight (2 cm of water) positive pressure which reduced the opportunity for inboard leaks of air from the atmosphere and was more comfortable than the standard aviator's mask. A Hewlett Packard w SONOS 1000 Doppler/Echo-Imaging System (Andover, MA) was used to monitor for VGE. This system permits both audio and visual monitoring and recording of gas emboli in all four chambers of the heart. VGE were graded on a 0 -4 integer modifi ed Spencer Scale ( 12 ) . For this report, any grade from 1 through 4 was considered to be a VGE event.
Procedures
Chamber ascent and descent rate did not exceed 1524 m z min 2 1 (5000 fpm) to and from 9144 m (30.1 kPa; 4.37 psia; 226 mmHg; 30,000 ft). Subject activity at 9144 m consisted of a 16-min sequence of exercise and VGE monitoring. Moderate activity consisting of upper-body exercises was performed by the subjects followed by 4 min of VGE monitoring. The subjects walked less than 10 steps between exercise stations and the echo-imaging station at 4-min intervals. The moderate exercises simulated EVA activities and each lasted 4 min: A) handcranked cycle ergometer (24 rpm; 20 W); B) torque wrench (25 ft-lb or 33.9 Nm with an 18 " torque wrench) for 5 s each position); and C) rope pull (pulley with 17 lb or 7.7 kg) of weight lifted. To provide relief from boredom and more closely emulate operational distractions, action-oriented movies were shown to the subjects during the hypobaric exposures and the subjects were not questioned about how they felt during the altitude exposures. Each subject was alone in the chamber while at altitude. The echo imaging transducer was placed using a robotic arm operated from outside the chamber. The subjects were instructed to report any changes in wellbeing to the Medical Monitor and the determination to terminate the exposure was made from these reports. The subjects were examined after recompression to ground level. The Medical Monitors were trained in the diagnosis of DCS and had the ability to consult with the physicians in Hyperbaric Medicine within the same building. Endpoints of the exposures were: 1) completion of the scheduled exposure period, 2) diagnosis of DCS, or 3) detection of left ventricular gas emboli. A more detailed description of the endpoints can be found elsewhere ( 10 ) .
Three BiP profi les were tested. The breathing gas during all PreOx and exposure periods was 100% O 2 . All
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PreOx was done at " ground level " (180 m above sea level). During the PreOx period subjects were in a seated position. The three profi les tested were identical except for the duration of the air break occurring during the PreOx period. Subjects were exposed to 30 min of PreOx, followed by either a 10-min (32 men, 8 women), 20-min (34 men, 6 women), or 60-min (29 men, 3 women) air break, and then completed the remaining 30 min of PreOx. The subjects then began a 4-h altitude exposure to 30.1 kPa (4.37 psia). Control data to compare against the three BiP profi les were taken from previous studies documented in our DCS database which used identical altitude and activity while decompressed, but were preceded by an uninterrupted 60-min prebreathe ( 15 ) . There were two basic control profi les. One control profi le (28 men) ( 13 ) used an altitude exposure of 4 h and the subjects performed their PreOx in a supine position. In the other control profi le (67 men), the altitude exposure lasted only 2 h, and PreOx was performed in a seated position. Although not signifi cant ( P . 0.050), the seated PreOx did yield 7% more DCS, which may refl ect a slight advantage of better venous return with improved tissue perfusion while supine, hence better denitrogenation effi ciency. This effect is consistent with the data reported by Balldin ( 1 ) . In this paper, our goal was to use the maximum amount of available data when comparing the BiP profi les with the controls. Thus, for comparisons during the fi rst 2 h of altitude exposure, all 95 (28 1 67) controls were used and for comparisons involving exposure times greater than 2 h, only the 28 controls exposed for 4 h were used.
Analysis
A 2-stage process was employed for statistical comparisons of DCS and VGE (any grade) cumulative incidence between the three BiP profi les, and between the BiP profi les and the control data. First, to obtain an overview of the DCS and VGE distributions, we calculated Kaplan-Meier estimates of the survival functions (accounting for censored observations) for each of the BiP and control profi les. Survival time, in our study, is defi ned as the elapsed time from the start of the altitude exposure to the fi rst report of a DCS symptom (or VGE event). The survival curves were then compared using the TaroneWare log-rank test, with P 5 0.05 as the signifi cance level. The second stage was to compare the four profi les (three BiP profi les plus control) at critical points in time. Specifi cally, Pearson's Chi-square tests were used to test for differences in DCS (or VGE) cumulative incidence at 1, 2, and 4 h into the altitude exposure. Since there is no scientifi c rationale to suggest that BiP will reduce DCS risk, our alternative hypothesis for these tests was that BiP would increase DCS risk compared to controls. Therefore, the signifi cance level was set at P 5 0.05, 1-tailed. All of the statistical tests reported in this paper require an underlying assumption of independence among the subject groups. This is not strictly the case in our study. The experimental design was not " repeated measures " nor was it strictly " independent " (i.e., using different subjects for each of the four profi les). The design was a mixture of both. For example, only 6 of the 95 subjects who performed a control exposure also performed 1 of the 3 air breaks. Therefore, we considered our 95 controls as independent of the 3 air breaks. There were 15 subjects who performed all 3 air breaks, 16 who performed 2 air breaks, and 18 who performed only 1 air break. So clearly our air break exposures are a mixture of independent and repeated measures. In addition, we did not control for any trial order effect. For practical reasons, given a large number of transient military subjects in a study lasting about 3 yr, those subjects who did repeat exposures performed the 10-min break fi rst, then the 20-min, and fi nally the 60-min break. We assume that the mixed sample design and any trial order effect had a minimal infl uence on our conclusions. Table I shows the anthropometric and physiologic means and standard deviations for the control and BiP test subjects. Note that 2 sets of results are shown for the controls: one for the 28 subjects who participated in the 4-h exposure protocol, and one for the entire group of 95 subjects (28 1 67). The anthropometric and physiologic means for the three BiP profi les are nearly identical, refl ecting the fact that many of the same subjects participated in multiple BiP profi les. One-way ANOVAs and post hoc multiple comparison Tukey HSD tests were used to compare the BiP and control means. We found the means to be very similar for the majority of the measures. However, a few differences were detected. Mean percent body fat was signifi cantly lower in all three BiP groups compared to the 4-h controls [ANOVA F(3,99) 5 6.09, P 5 0.001; Tukey P , 0.01 in each case]. Also, mean age was signifi cantly higher in the 20-min and 60-min BiP groups compared to both control groups [ANOVA F(3,203) 5 4.15, P 5 0.007 and F(93,136) 5 4.14, P 5 0.008 for comparisons with 2 h and 4 h, respectively; Tukey P , 0.05 in each case].
RESULTS
The distributions of the cumulative incidence of DCS are shown in Fig. 1 for the three BiP profi les and for controls. There are 3 curves presented for controls representing: 28 subjects with 4 h exposure; 67 subjects with 2 h exposure; and the 95 combined subjects covering the fi rst 2 h. From a visual inspection of the fi gure, it appears that the three BiP curves are similar in shape, and that they differ from the control curves, with the differences occurring chiefl y in the early part of the exposure. The Tarone-Ware log-rank tests, when performed on the 4-h curves, did not fi nd differences among the three BiP curves, but the 60-min BiP curve differed signifi cantly from the control curve [ x 2 (1df) 5 3.85, P 5 0.050] and the test of the 20-min BiP curve vs. control curve approached signifi cance [ x 2 (1df) 5 3.63, P 5 0.057]. The Tarone-Ware tests on the 2-h curves, which tended to be more powerful due to the increased sample size in the control group, again did not detect differences among the three BiP curves. However, the 20-min and 60-min BiP curves were statistically different from the control curve [ To provide insight into the results found with the Tarone-Ware tests, cumulative DCS rates at specifi c time points were extracted from the DCS curves for each profi le and compared. The Chi-square tests found no significant differences among the three BiP profi les at any time point ( P -values not shown in the table). However, the DCS rates of all three BiP profi les were signifi cantly higher than the control DCS rate at 1 h into the exposure [ . At 4 h of exposure, no differences were detected between BiP profi les and control.
Distributions of VGE cumulative incidence are shown in Fig. 2 for the BiP profi les and controls. Visual inspection shows that, regardless of the profi le used, VGE incidence increased fairly rapidly after exposure began. The BiP curves do not appear to differ from each other or from the 2-h control curve. The control curve based on the 4-h exposure subjectively appears to be slightly lower than the other curves. However, the Tarone-Ware tests did not detect signifi cant differences among the BiP curves nor between any BiP curve and either control curve. VGE rates at specifi c time points were extracted from the curves and are presented in Table II . Even though the Tarone-Ware tests were not signifi cant, Chi-square tests were performed to compare profi les and no significant differences were found (test results not shown in the table).
The distributions of the types of DCS symptoms observed in our study are shown in Table III . The fi ve categories shown were chosen from previous AFRL and NASA publications ( 3, 2, 8, 11 ) . Although some headaches may result from other causes, the majority are very likely CNS symptoms. Retrospective clarifi cation is not possible based on available data ( 6 ) . From the table we see that the most common DCS symptom occurring in all groups was joint pain, representing 53% of all symptoms seen in the control group and ranging from 46 to 61% in the BiP groups. The second most common symptom in all groups was skin manifestations (18% in controls and ranging from 17 to 34% in the BiP groups. The remaining three symptom types occurred relatively infrequently in all groups, with no one symptom exceeding 14% in any group. These results suggest that the relative distribution of symptom types in each of the BiP groups mirrored the distribution seen for the controls. Fat and VO 2peak measurements were not available for all subjects. Numbers in parentheses show the actual sample sizes for these two variables. * Signifi cantly different from the 4-h control mean ( P , 0.01, Tukey HSD test). ** Signifi cantly different from the 2-h and 4-h control means ( P , 0.05, Tukey HSD test). Fig. 1 . Cumulative % DCS vs. time at altitude for controls and three air break conditions.
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DISCUSSION
Defi nitive data using current acceptable endpoint criteria for evaluating altitude DCS risk associated with air breathing breaks in PreOx is not available. Direct measurement of denitrogenation/renitrogenation in the tissues of the body is not now technically feasible. Indirect measurement of this process using DCS symptomatology and intravascular bubble detection (VGE) was used in this study. DCS symptoms are subjective, whereas measurement of VGE is objective.
Our results showed that air breaks in PreOx did not change the relative distribution of the types of DCS symptoms compared to controls: joint pain was the predominant symptom in the BiP and control groups; skin manifestations were the second most prevalent in all groups; and occurrence of the remaining symptoms was mixed, but infrequent. On the other hand, the data did show signifi cant differences between the BiP groups and controls with respect to the overall incidence of DCS. Fig. 1 gave a visual impression that the cumulative DCS incidence curves for the BiP groups were different from the control curves and this impression was confi rmed by the Tarone-Ware tests. The follow-up tests at specifi c time points indicated that there was an increased risk of DCS in the BiP groups, compared to control, during the early part of the altitude exposure. At 1 h into the exposure, the cumulative DCS rates of all three BiP groups were signifi cantly higher than that of the controls, and after 2 h of exposure, the 20-min and 60-min BiP rates remained higher than the control rate. We did not fi nd signifi cant VGE incidence differences among the BiP profi les and control at any point during altitude exposure. The VGE incidence rate increased rapidly very early into the exposure in all groups and exceeded 70% in each group by 2 h of exposure.
The fact that the DCS rates of the BiP profi les and controls become similar toward the end of 4 h of altitude exposure is probably due to two factors. First, there is a " ceiling effect. " Mathematically, DCS rates cannot exceed 100% (the ultimate ceiling), but since there are some subjects who are naturally resistant to DCS ( 16 ), a more likely ceiling is around 75 -80%. The BiP DCS rates reach that point early and can go no higher, whereas the control DCS rates rise more gradually, but eventually reach that same ceiling. Second, during the altitude exposure, denitrogenation continues since subjects are breathing 100% O 2 . It is likely that this additional " denitrogenation period " has been suffi cient to reduce N 2 in the BiP subjects ' slow tissues (such as joints, which have low perfusion) to levels comparable to those in the controls.
Because the DCS rates of the BiP and control subjects were similar toward the end of the 4-h exposures, one might be willing to assume that, for a prolonged operational mission, breaks in PreOx do not matter since the ultimate risks of DCS are the same. The danger with this assumption is that we do not know the incidence rates of serious DCS events (debilitating joint pain, serious neurologic events, etc.). In research studies, once a subject experiences any DCS symptom, the exposure is terminated for the safety of the subject. Consequently, we do not have a clear understanding of how many subjects with mild symptoms might have gone on to develop serious DCS events. However, we surmise that, once an individual develops symptoms, they are likely not to improve, and may worsen. Thus we argue that, in an operational setting 
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(where resolution of a symptom may not be immediately possible), the more participants that develop DCS early in an exposure, the larger the number that may progress to serious events which could impact the outcome of the mission and/or the well-being of the participant.
There are potential shortcomings of the data used in this study. One criticism is that our data was a mixture of independent and repeated measures, and that, for the repeated measures, the order of profi les was not balanced. We argue that since only 6 of the 95 control subjects participated in any BiP profi le, the most important comparisons (any BiP vs. control) were essentially performed with independent data, thus satisfying the criterion of the statistical tests. There might also be concerns that the control and BiP subjects represent different anthropometric/physiologic populations since, statistically, average body fat was higher and age was lower in the controls. Realistically, the average ages were within about 4-5 yr of each other and were all well within the age range of the active military population. The body fat differences might be of more concern, but, again, the averages all fall within the range of those seen in relatively fi t personnel. Also, since the body fat averages are based on smaller sample sizes due to missing data, we are less confi dent that they are good representations of the population averages. Finally, one may wonder, since there were no women in the control group, what impact the small number of women in the BiP groups had on the results. Webb et al. ( 14 ) did not fi nd gender differences with respect to DCS. Furthermore, since the operational groups of interest in this study (e.g., U-2 pilots) are comprised of both genders, we felt that it was important to include the women in our analyses. However, had we eliminated them, we would have found the same signifi cant effects that we have reported in this paper.
This study was designed to cover a wide range of air breaks (10 to 60 min), with one goal being to estimate a " safe " limit for air breaks that would have operational value. We originally hypothesized that breaks of 10 or 20 min during a 1-h PreOx would not increase the risk of DCS compared to no break. Our results disproved this hypothesis. It is very reasonable to assume that a break of just a few breaths (such as might occur if a mask adjustment were necessary) would likely not alter the protection provided by the PreOx. But what is the effect of a 5-min, 3-min, or even 1-min break? The slightly less pronounced effects seen for the 10-min BiP compared to the 20-and 60-min BiPs suggest that a safe limit does exist. A related issue concerns the timing of the air break. In this study, an air break Ն 10 min occurring at the midpoint of a 1-h PreOx increased the risk of developing DCS during at least the fi rst 2 h of a subsequent 9144-m (30,000-ft) altitude exposure, compared to that same exposure with no air break. Would an earlier air break have had less impact on DCS rates, or a later air break a more profound effect? And, of course, the more complex question: What effect does the length of the air break combined with the time of its occurrence have on the protection provided by PreOx? These questions, and others, remain unanswered.
